Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine.
Eighteen patients with moderate to severe pulmonary hypertension were studied, nine with intracardiac shunts and nine without. The effects of an incremental infusion of epoprostenol (prostacyclin) (0.5-8 ng/kg per minute) or sublingual nifedipine (20-30 mg) were compared with the response to three m...
Main Authors: | Rozkovec, A, Stradling, JR, Shepherd, G, MacDermot, J, Oakley, C, Dollery, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
1988
|
Similar Items
-
VARIABLE RESPONSE TO VASODILATOR THERAPY IN PRIMARY PULMONARY-HYPERTENSION
by: Rozkovec, A, et al.
Published: (1982) -
VALUE OF ACUTE VASODILATOR STUDIES IN MANAGEMENT OF PRIMARY PULMONARY-HYPERTENSION
by: Rozkovec, A, et al.
Published: (1982) -
Hydralazine in pulmonary hypertension.
by: Rozkovec, A, et al.
Published: (1982) -
Coral assemblages at higher latitudes favour short-term potential over long-term performance
by: Cant, J, et al.
Published: (2023) -
Divergent roles of prostacyclin and PGE2 in human tendinopathy.
by: Bergqvist, F, et al.
Published: (2019)